BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29938370)

  • 1. Quantification of total dinutuximab concentrations in neuroblastoma patients with liquid chromatography tandem mass spectrometry.
    El Amrani M; Szanto CL; Hack CE; Huitema ADR; Nierkens S; van Maarseveen EM
    Anal Bioanal Chem; 2018 Sep; 410(23):5849-5858. PubMed ID: 29938370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A generic sample preparation method for the multiplex analysis of seven therapeutic monoclonal antibodies in human plasma or serum with liquid chromatography-tandem mass spectrometry.
    Amrani ME; Gerencser L; Huitema ADR; Hack CE; van Luin M; van der Elst KCM
    J Chromatogr A; 2021 Oct; 1655():462489. PubMed ID: 34509691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
    Li W; Lin H; Fu Y; Flarakos J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a dinutuximab delivery system using silk foams for GD2 targeted neuroblastoma cell death.
    Ornell KJ; Chiu B; Coburn JM
    J Biomed Mater Res A; 2021 Aug; 109(8):1393-1405. PubMed ID: 33252182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous Quantification of Free Adalimumab and Infliximab in Human Plasma Using a Target-Based Sample Purification and Liquid Chromatography-Tandem Mass Spectrometry.
    El Amrani M; Bosman SM; Egas AC; Hack CE; Huitema ADR; van Maarseveen EM
    Ther Drug Monit; 2019 Oct; 41(5):640-647. PubMed ID: 31584927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High throughput identification and quantification of 16 antipsychotics and 8 major metabolites in serum using ultra-high performance liquid chromatography-tandem mass spectrometry.
    Patteet L; Maudens KE; Sabbe B; Morrens M; De Doncker M; Neels H
    Clin Chim Acta; 2014 Feb; 429():51-8. PubMed ID: 24291056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Concurrent Measurement of Gabapentin, Lamotrigine, Levetiracetam, Monohydroxy Derivative of Oxcarbazepine, and Zonisamide Concentrations in Serum in a Clinical Setting.
    Palte MJ; Basu SS; Dahlin JL; Gencheva R; Mason D; Jarolim P; Petrides AK
    Ther Drug Monit; 2018 Aug; 40(4):469-476. PubMed ID: 29994986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment.
    Seitz CM; Flaadt T; Mezger M; Lang AM; Michaelis S; Katz M; Syring D; Joechner A; Rabsteyn A; Siebert N; Troschke-Meurer S; Zumpe M; Lode HN; Yang SF; Atar D; Mast AS; Scheuermann S; Heubach F; Handgretinger R; Lang P; Schlegel P
    Front Immunol; 2021; 12():690467. PubMed ID: 34367149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle-up quantification of therapeutic monoclonal antibodies in human plasma with two dimensional liquid chromatography high resolution mass spectrometry: Adalimumab as a proof of principle.
    Amrani ME; van der Elst KCM; Huitema ADR; van Luin M
    J Chromatogr A; 2022 Feb; 1665():462840. PubMed ID: 35121176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous quantification of busulfan, clofarabine and F-ARA-A using isotope labelled standards and standard addition in plasma by LC-MS/MS for exposure monitoring in hematopoietic cell transplantation conditioning.
    Punt AM; Langenhorst JB; Egas AC; Boelens JJ; van Kesteren C; van Maarseveen EM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jun; 1055-1056():81-85. PubMed ID: 28445850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque.
    Helmschrodt C; Becker S; Schröter J; Hecht M; Aust G; Thiery J; Ceglarek U
    Clin Chim Acta; 2013 Oct; 425():3-8. PubMed ID: 23827692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local delivery of dinutuximab from lyophilized silk fibroin foams for treatment of an orthotopic neuroblastoma model.
    Ornell KJ; Taylor JS; Zeki J; Ikegaki N; Shimada H; Coburn JM; Chiu B
    Cancer Med; 2020 Apr; 9(8):2891-2903. PubMed ID: 32096344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of coagulation factor VIII in human plasma with liquid chromatography tandem mass spectrometry using a selective sample purification with camelid nanobodies.
    El Amrani M; Donners AAM; Graat G; Lentjes EG; Huisman A; Musson REA; van Maarseveen EM
    J Pharm Biomed Anal; 2019 Oct; 175():112781. PubMed ID: 31398627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.
    Zanchetta M; Iacuzzi V; Posocco B; Bortolin G; Poetto AS; Orleni M; Canil G; Guardascione M; Foltran L; Fanotto V; Puglisi F; Gagno S; Toffoli G
    PLoS One; 2021; 16(10):e0259137. PubMed ID: 34699578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of T Cell Binding Polyclonal Rabbit Anti-thymocyte Globulin in Human Plasma with Liquid Chromatography Tandem-Mass Spectrometry.
    Amrani ME; Admiraal R; Willaert L; Ebskamp-van Raaij LJC; Lacna AM; Hack CE; Huitema ADR; Nierkens S; van Maarseveen EM
    AAPS J; 2020 Feb; 22(2):43. PubMed ID: 32030538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms, Characteristics, and Treatment of Neuropathic Pain and Peripheral Neuropathy Associated with Dinutuximab in Neuroblastoma Patients.
    Mastrangelo S; Rivetti S; Triarico S; Romano A; Attinà G; Maurizi P; Ruggiero A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
    Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F; Zimmermann S; Kurlbaum M; Jung P; Pelzer T; Klinker H; Isberner N; Scherf-Clavel O
    Anal Bioanal Chem; 2021 Jan; 413(2):599-612. PubMed ID: 33155133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits.
    Truffot A; Jourdil JF; Seitz-Polski B; Malvezzi P; Brglez V; Stanke-Labesque F; Gautier-Veyret E
    Clin Biochem; 2021 Jan; 87():60-66. PubMed ID: 33096054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.